Background: Overactivated microglial cells exhibit chronic inflammatory response and can lead to the continuous production of pro-inflammatory cytokines, perpetuating inflammation, and ultimately resulting in neuronal injury. 1,2,3,4,6-Penta-O-Galloyl-β-D-Glucose (PGG), which is a naturally occurring polyphenolic compound, has exhibited anti-inflammatory effect through the inhibition of many cytokines in different experimental models, but its effect on activated microglia cells was never described. In the present study, we investigated PGG effect in proteins involved in the NFƙB and MAPK signaling pathways, which play a central role in inflammation through their ability to induce transcription of pro-inflammatory genes. Methods: PCR arrays and RT-PCR with individual primers were used to determine the effect of PGG on mRNA expression of genes involved in NFƙB and MAPK signaling pathways. Western blots were performed to confirm PCR results. Results: The data obtained showed that PGG modulated the expression of 5 genes from the NFƙB (BIRC3, CHUK, IRAK1, NFƙB1, NOD1) and 2 genes from MAPK signaling pathway (CDK2 and MYC) when tested in RT-PCR assays. Western blots confirmed the PCR results at the protein level, showing that PGG attenuated the expression of total and phosphorylated proteins (CDK2, CHUK, IRAK1, and NFƙB1) involved in NFƙB and MAPK signaling. Conclusion: These findings show that PGG could modulate the expression of genes and proteins involved in the production of pro-inflammatory cytokines in microglia cells.
Introduction
Chronic microglial activation induces the overproduction of proinflammatory mediators, such as pro-inflammatory cytokines (Streit et al., 2004) , and might override the beneficial effect of these cells in the CNS (Schwartz and Baruch, 2014) . In the state of prolonged inflammation, continual activation and recruitment of effector cells can establish a feedback loop that perpetuates inflammation and ultimately results in neuronal injury (Gendelman, 2002; Oh et al., 2004) . The activation of microglial cells is observed in brain injuries and is induced after the exposure to the Gram-negative bacterial coat component, lipopolysaccharide (LPS) (Hanisch, 2002) . Microglial activation is a highly potent trigger for cytokine synthesis through Toll-like receptor 4 (TLR4) (Hanisch, 2002) , interferon-γ (IFNγ), or amyloid β (Aβ) (Lacy and Stow, 2011; Giulian et al., 1994) . The released pro-inflammatory cytokines play a key role in the induction and maintenance of neuroinflammation. Numerous studies confirmed that the levels of classical pro-inflammatory cytokines are elevated in chronic neurodegenerative diseases, especially in Alzheimer's disease (AD) and significantly contribute to this disease progression (Smith et al., 2012; Zheng et al., 2016; Rocha et al., 2012) . This inflammation process is mediated by pro-inflammatory cytokines and would create a chronic and self-sustaining inflammatory interaction between activated microglia and astrocytes, stressed neurons, and amyloid β (Aβ) plaques (Rubio-Perez and Morillas-Ruiz, 2012). Also, Aβ can stimulate a nuclear factor-kappa B (NFƙB) dependent pathway which is required for cytokine production
